Loading...
XASX
CAN
Market cap4mUSD
Dec 05, Last price  
0.01AUD
1D
0.00%
1Q
-30.77%
IPO
-98.65%
Name

Cann Group Ltd

Chart & Performance

D1W1MN
XASX:CAN chart
P/E
P/S
0.41
EPS
Div Yield, %
Shrs. gr., 5y
26.37%
Rev. gr., 5y
42.59%
Revenues
15m
+11.58%
13,7426,6628,421605,6462,607,941647,2224,293,0006,411,00013,777,00015,373,000
Net income
-51m
L+51.65%
-4,176,446-1,462,011-2,588,445-4,725,857-10,926,317-16,937,387-25,103,000-26,468,000-33,790,000-51,242,000
CFO
-15m
L-33.50%
-642,737-1,246,727-2,298,851-3,754,511-7,422,547-17,618,574-20,830,000-20,433,000-22,835,000-15,185,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
IPO date
May 04, 2017
Employees
40
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT